1、Cell-based Therapeutics

Mesenchymal stem cells are a type of multipotent stem cells capable of differentiating into bone cells, fat cells, and cartilage cells. They can reduce inflammation, decrease tissue cell apoptosis, promote endogenous tissue organ stem cell proliferation, and engage in immune modulation through the secretion of cytokines. Therefore, they can serve as seed cells for tissue and organ repair. 

YHZK has developed three products targeting knee osteoarthritis, diabetic foot, and uterine adhesions.

2、harmaceutical-Grade Cell Formulations

（1）、MSC Local Injection Formulation

 Mesenchymal Stem Cell Injection

Specification: 2mL with 2.0*10^7 cells

Indication: Knee osteoarthritis

BAOMAI001 injection is a cord mesenchymal stem cell product that has successfully completed cell preparation process development, construction of a tiered cell bank, formulation process development, process parameter research, comprehensive quality research, and stability research. It is currently in the IND phase.

（2）、MSC Intravenous Injection Formulation

MSC Injection

Product Specification: 1×10^7-10×10^7 cells (as needed), 100mL/bag

Instructions: Intravenous infusion

Healthy umbilical cords are collected from rigorously screened donors. Pure primary cells are isolated using Huatong's collagenase digestion, undergo large-scale cultivation, and are induced to secrete extracellular vesicles. After purification and successful testing, the pharmaceutical-grade cell formulation is obtained.